International registry for renal stone treatment outcomes
A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Urinary Calculi - International Registry
This study is trying to see how different surgical treatments for kidney stones work and what factors affect their success, so doctors can choose the best options for their patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 3 sites (Hong Kong and 2 other locations) |
| Trial ID | NCT05297331 on ClinicalTrials.gov |
What this trial studies
This international prospective data registry aims to evaluate the treatment outcomes and complications associated with various surgical approaches for urolithiasis. It focuses on understanding how different factors, such as stone characteristics and patient preferences, influence treatment decisions and success rates. By collecting and analyzing data from multiple hospitals, the registry seeks to provide valuable insights that can guide clinicians in selecting the most appropriate treatment for individual patients. The study also aims to assess the impact of new technological advancements on treatment efficacy.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients aged 18 and above who are experiencing urolithiasis.
Not a fit: Patients who are unable to give consent will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance treatment decision-making for patients with renal stones, leading to improved outcomes and reduced complications.
How similar studies have performed: While there have been various studies on urolithiasis treatment, this registry approach is relatively novel in its comprehensive data collection across multiple institutions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient at the age of 18 or above Exclusion Criteria: * Patient is unable to give consent
Where this trial is running
Hong Kong and 2 other locations
- Alice Ho Miu Ling Nethersole Hospital — Hong Kong, Hong Kong (Recruiting)
- Prince of Wales Hospital — Shatin, Hong Kong (Recruiting)
- North District Hospital — Sheung Shui, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Chi Fai NG, MD — Chinese University of Hong Kong
- Study coordinator: Chi Fai NG, MD
- Email: ngcf@surgery.cuhk.edu.hk
- Phone: 35052625
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.